Votre navigateur ne supporte pas le javascript Wallonia & Brussels against COVID-19 - University

University

A. Bengoetxea - P. D'Ans - J. Foucart - M. Schetgen - A. Spinewinne - L. Di Biagi - F. Defraine - M. Karam - J. Mellier - Q. Vanderhofstadt

ULB, UCLouvain, Université de Montréal
" OBJ: 1) Observe interprofessional and interorganisational collaboration "in the making" in crisis situation: how professional groups organize and collaborate (within and between professional groups) in different organizational contexts (liberal practice, primary care delivery services, hospitals, nursing homes, etc.) especially for vulnerable groups. 2) Analyse the role of regulatory bodies governmental agencies, professional associations) in managing healthcare professions and interprofessional collaboration in crisis situations 3)Improving future care and the resilience of health systems METH: Collection and analysis of documents (instructions, tools, etc.), qualitative interviews, in situ observations. Developing Grounded theory "
Funding: Research team is part of BeHive - Interdisciplinary primary care Chair, funded by the King Baudouin Foundation (Fund Dr. Daniel De Coninck)
Contact: celine.j.mahieu@ulb.be

Adélaïde de Heering, Post-doctoral Fellow

ULB

Sphère publique, sphère privée : Impact du port du masque sur la reconnaissance des personnes et de l'expression émotionnelle de leur visage. " Le déconfinement approche. Bientôt la population belge sillonnera à nouveau les rues, les transports et l'ensemble de l'espace public mais munie de masques. Quels retentissements sur la capacité des personnes à en reconnaître d'autres sur base de leur visage et à en extraire l'expression émotionnelle ? Sera-t-on toujours capable de juger, de manière efficace, de l'intention d'autrui à notre égard même si cette dernière porte un masque ? A tous les âges ? Ou, au contraire, a-t-on raison d'avoir la suspicion que le port du masque pourrait nous empêcher de reconnaître quelqu'un sur base de son visage et d'en lire les émotions de manière efficace ? "
Publication References: de Heering, A., & Rossion, B. (2008). Prolonged Visual Experience in Adulthood Modulates Holistic Face Perception. PlosOne, 3(5): e2317. de Heering, A., &amp...

Alexandre Legrand, Professor

UMONS/ Haute école Condorcet/ UCLouvain/ Epicura/ Machine sight
" In view of the risk of a respirator shortage in intensive care units throughout the world following the COVID 19 epidemic, a simple solution based on existing means or means that are easy to implement is being sought by a consortium of respiratory physiotherapists, researchers of UMONS, physicians of the the intensive care unit of the Epicura hospital and a mechatronics engineering company. In view of the risk of a respirator shortage in intensive care units throughout the world following the COVID 19 epidemic, a simple solution based on existing means or means that are easy to implement is being sought by a consortium of respiratory physiotherapists, researchers of UMONS, physicians of the the intensive care unit of the Epicura hospital and a mechatronics engineering company. "
Funding: internal funding
Contact: Pr. Alexandre Legrand, head of the laboratory of Physiology and Respiratory Rehabilitation...

André Matagne, Alain Brans, Marylène Vandevenne, Maximiliano Figueroa, Moreno Galleni, Romain Malempré

ULiège - Royal Academy of Sciences, Letters and Fine Arts of Belgium
"The Centre for Protein Engineering (CIP, ULiège), through its two technological platforms, has been involved in the production of reagents (i.e. proteins) for diagnostic and analyses of SARSCoV-2 infection. In particular, Protein Factory has produced a pure and highly active enzyme (CAS12) for a CRISPR/CAS assay, which, in combination with classical PCR technology allows rapid detection of the virus. Automated screening is currently performed at Robotein for optimal formulation of CAS12. The production of complementary protein reagents for such tests is underway. Furthermore, in a collaborative effort with Dr Arnaud Marchant at Institut d'Immunologie Médicale (ULB), the CIP is involved in the design and production of recombinant SARS-COV-2 antigens towards the development of a platform for high dimensional systems serology analysis of SARS-CoV-2 antibodies."
Contact: André Matagne amatagne@uliege.be 

Benoît Herman

UCLouvain
" Breath4Life is a voluntary, non-profit, and open source effort by a distributed team of engineers, doctors, industry players, to design, test and spread medical ventilators - low cost but as close as possible to existing medical devices. Starting from international standards and guidances, we designed and tested successfully functional prototypes with Volume Controlled Ventilation for intubated patients. We now focus on more advanced modes (including respiratory assistance for patients breathing spontaneously), on intensive testing, and on writing the documentation required for supporting partners around the world to adapt, build and validate their replica. "
Contact: http://breath4life.org/ 

Bernard Pirotte, Professor - Marianne Fillet, Professor - Philippe Hubert, Professor - Pierre Francotte, Assistant Professor

ULiège, CIRM - Royal Academy of Medicine of Belgium
" The pandemic has highlighted a critical need of local production of essential drugs used in first-line emergency care of COVID-19 patients. The present consortium has developed a dedicated unit to address this need (both organic synthesis and quality control) following strict quality assurance rules observed by the pharmaceutical industry. The pandemic has highlighted a critical need of local production of essential drugs used in first-line emergency care of COVID-19 patients. The present consortium has developed a dedicated unit to address this need (both organic synthesis and quality control) following strict quality assurance rules observed by the pharmaceutical industry. "
Contact: Prof. Marianne FILLET, CIRM Director, University of Liège https://www.cirm.uliege.be marianne.fillet@uliege.be

Bernardo Innocenti, Professor

ULB
" The aim is to develop and validate a numerical model of a human lung to predict its degeneration over time, in order to provide better knowledge and further info for decision-making to the clinician, addressing both the treatment and the follow-up of the patients after the pathology. "
Contact: bernardo.innocenti@ulb.ac.be

Caroline Daelemans, Professor

ULB
"Our objectives are: • To study maternal and neonate COVID-19 information in the Belgian-Obstetric Surveillance System database: clinical presentation and natural history of disease, pregnancy-related basic information, pregnancy outcomes, birth characteristics, infant morbidity and mortality. • To study the core socio-demographic information to potentially identify groups at higher risk of complications • Build a more informative dataset thanks to data mining of public databases This study will enable us to understand the impact of COVID-19 on pregnant women and their offspring in Belgium, and in the world via the contribution to the INOSS multicenter study. It might allow us to define an at-risk population among pregnant women and their offspring, and tailor epidemiologic and clinical interventions for these more vulnerable individuals."
Funding: Pending (FNRS)
Publication References: "1. The International Network of Obstetric Survey Systems study of uterine rupture: a...

Caroline Daelemans, Professor

ULB
" COVerT Our aim is to delineate more accurately the prevalence of the infection in the pregnant population and study vertical transmission in the cord blood of babies born to mothers with confirmed SARS-CoV-2 infection. Determination of prevalence of SARS-CoV-2 infection in mothers by combined universal screening: presence of antibodies (IgG and IgM or IgA) in their blood and/or a positive RT-PCR in the nasopharyngeal swab. We intend to detect evidence of vertical transmission by the identification of SARS-CoV-2 specific IgM or IgA in cord blood samples. If there is evidence of vertical transmission, the analysis of the consequences depending on infection timing during pregnancy will enable us to guide management more precisely. "
Funding: pending FNRS
Publication References: "1. Delforge ML, Costa E, Brancart F, Goldman D, Montesinos I, Zaytouni S, Marchant A, Donner C Presence of cytomegalovirus in urine and blood of pregnant women with primary infection might be associated...

Caroline Huart, MD, PhD - Bernard Hanseeuw, MD, PhD - Valérie Hox, MD, PhD - Pascal Kienlen-Campard, PhD- Vincent Van Pesch, MD, PhD

UCLouvain and Cliniques universitaires Saint-Luc - FNRS
" Anosmia has been reported to be a major symptom of COVID-19. Since high viral loads are found in the nasal cavity of patients and since single-cell analyses found that olfactory sustentacular and stem cells highly express ACE2 and TMPRSS2, it is suspected that cells of the olfactory neuroepithelium are a preferred target of the virus. Some COVID-19 patients present with neurological symptoms. Interestingly, it has been reported that the former SARS-CoV, can ascend intracranially, possibly via the olfactory nerves. Since olfactory receptor neurons form a direct connection between the nasal cavity and the brain, we hypothesize that these cells act as a gateway towards the brain in some patients. The main aims of the projects are (1) to investigate the pathophysiology of COVID-related olfactory dysfunction and (2) to investigate whether olfactory receptor neurons could be the entry site of SARS-CoV2 to the brain. "
Funding...

Cécile OURY, FNRS Research Director

GIGA - ULiège - FNRS
" Covid-19 is associated with a high risk of thrombotic disease, both in the venous and arterial circulations. As President of the Belgian Society on Thrombosis and Hemostasis (BSTH), I am coordinating the creation of national algorithms for thromboprophylaxis and anticoagulation of Covid-19 patients by a group of experts. These algorithms will be included in the Sciensano Covid-19 guidelines. "
Publication References: In preparation
Contact: Cécile Oury, PhD President of the Belgian Society on Thrombosis and Haemostasis Research Director F.R.S.-FNRS Head of the Laboratory of Cardiology GIGA-Cardiovascular Sciences University of Liège (B34) 1 Avenue de l'Hôpital 4000 Liège (Sart-Tilman) Belgium Tel: +32 (0)4 366 24 87 cecile.oury@uliege.be

Charles Nicaise, Professor

UNamur
" In vitro studies will investigate the abilities of SARS-Cov-2 to enter various types of human neurons (cell lines and iPS-derived) and possible axoplasmic transport. In the meantime, analysis of post-mortem CNS and PNS samples from COVID patients would strengthen the hypothesis of SARS-Cov-2 neuro-tropism. "
Funding: CUR-FNRS (pending)
Contact: charles.nicaise@unamur.be

Charles Pilette, Professor

UCLouvain, St-Luc
" We aim to characterize the reprogramming of structural cells of the lungs that are direct targets of the SARS-CoV-2, namely type 2 alveolar epithelial cells and endothelial cells, as well as their potential role in the induction of the (hyper)inflammatory phase of the disease leading to acute lung injury. The skills of our laboratory in lung and mucosal immunology research that are relevant to this field are (1) access to precious human lung tissue (e.g. from SARS-CoV-2 patients), (2) multiplex immunofluorescence staining and isolation of structural cells (e.g. alveolar epithelial cells, endothelial cells) from the human lung, as well as (3) their characterization using cell culture-based readouts and (in collab. with the UCL-CTMA) genetic sequencing. "
Funding: FNRS CUR, application submitted on 01-05-20.
Publication References: 1. Gohy ST, Hupin C, Fregimilicka C, Detry BR, Bouzin C, Gaide Chevronay H, Lecocq M, Weynand B, Ladjemi MZ, Pierreux CE, Birembaut P...

Christian Grandfils, Professor

ULiège CEIB
" Expert services for Federal Agency of Drug and Medical products "
Contact: C.Grandfils@uliege.be

Dan Lecocq, Maître de conférences

ULB 
" Aim: To describe and understand the consequences of the pandemy in a french-speaking teaching hospital a) on the nursing care b) on the nurse-patient interaction. Methods : qualitative research "
Funding: None
Contact: dan.lecocq@ulb.be

Contact us

c/o F.R.S. - FNRS

Rue d’Egmont 5

B - 1000 Bruxelles

Tél : +32 2 504 92 11

info@COVID19-WB.be

Brussels & Wallonia against COVID19

AcceptRead more about cookies

Disclaimer - Terms and conditions of use


The purpose of the provisions below is to define the conditions under which the F.R.S.-FNRS gives you access to this website www.COVID19-WB.be.

1. Acceptance of the general conditions of use

The F.R.S.-FNRS gives you access to the www.COVID19-WB.be website and the information contained therein, you accept these conditions. The F.R.S.-FNRS may modify them at any time.

2. Use of the website

The content of this website is provided to you for general information purposes only. The content of this website may only be used in connection with the services offered on the website and for your personal use. This website may not be used as a basis for any evaluation of the F.R.S.-FNRS and may in no way bind or be opposable to the F.R.S.-FNRS. Nothing on the website can be considered as an offer to purchase or provide services or to conclude a contract.

The user undertakes to use the website in compliance with the laws and legal and/or contractual notices. The user may not use it in any way that would prejudice the interests of the F.R.S.-FNRS and/or its partners.

3. Guarantees and limitations of liability for the use of the website

In general, the F.R.S.-FNRS cannot, under any circumstances, be held liable for direct or indirect damage, or for any other damage of any nature whatsoever, resulting from the use of this website or from the impossibility of using it for any reason whatsoever, whether or not this liability is contractual, tortious or quasi-delictual, or whether it is based on no-fault liability or otherwise, and this even if the F.R.S.-FNRS is not liable for any damage resulting from the use of this website or from the impossibility of using it for any reason whatsoever, whether or not this liability is contractual, tortious or quasi-delictual, or whether it is based on no-fault liability or otherwise, and this even if the F.R.S.-FNRS is not liable for any damage resulting from the use of this website. FNRS would have been advised of the possibility of such damages.

3.1 Information

The information on this site is the exclusive responsibility of its authors. The F.R.S.-FNRS uses all reasonable means to publish on this website information which, to its knowledge, is up to date. However, it does not guarantee the adequacy, accuracy or exhaustiveness of such information nor does it guarantee that the website will always be complete and up to date in all respects. The information contained on this website may contain inaccuracies in content, technical inaccuracies or typing errors. This information is provided for information purposes only and is subject to periodic changes. The F.R.S.-FNRS may be required to make improvements and/or changes to this website at any time and without notice.

The use of this website, and consequently the information obtained, or elements downloaded when using the service, is the sole responsibility of the user. The F.R.S.-FNRS declines all responsibility for any damage that may result from the use of the information on this website.

The user also acknowledges that he or she shall be solely responsible for any damage to his or her computer system or any loss of data resulting from the downloading of any content.

3.2. Hypertext links

This website contains hypertext links to other sites as well as references to other sources of information, which are provided for your information only. The F.R.S.-FNRS does not control these sites and the information contained therein and therefore cannot offer any guarantee as to the quality and/or exhaustive nature of this information.

The F.R.S.-FNRS declines all responsibility for any unsuitable, illegitimate or illegal content present on the hyperlinks as well as for any damage that may result from consulting them.

3.3. Acts of Internet users

The F.R.S.-FNRS shall in no way be held responsible for the actions of Internet users.

4. Intellectual property rights

The trademarks on the site (www.COVID19-WB.be) may not be used in connection with any product or service other than those of the F.R.S.-FNRS, in any way that is likely to create confusion or in any way that would depreciate or discredit the F.R.S.-FNRS.

Unless explicitly authorized to do so, the user may not, under any circumstances, copy, reproduce, translate, represent, modify, transmit, publish, adapt, distribute, broadcast, license, transfer, sell, on any medium whatsoever, by any means whatsoever, or exploit in any way whatsoever, all or part of this website without the prior written authorization of the F.R.S.-FNRS. Any infringement may result in civil and criminal prosecution.

AcceptRead more about cookies